Skip to main navigation Skip to search Skip to main content

Exploring the impact of melatonin on cancer-related fatigue: a dose-response meta-analysis with GRADE evidence evaluation

  • Sajjad Etesamnia
  • , Mahdiyar Nasiraie-Moghadam
  • , Pariya Mostafazadeh
  • , Mohammad Reza Jowshan
  • , Kamran Roudini
  • , Seyed Rohollah Miri
  • , Alireza Jahan-Mihan
  • , Alireza Haghighi
  • , Soraiya Ebrahimpour-Koujan
  • Harvard Medical School

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Article number880
JournalBMC Cancer
Volume26
Issue number1
DOIs
StatePublished - May 26 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus Subject Areas

  • Oncology
  • Genetics
  • Cancer Research

Keywords

  • Cancer-related fatigue
  • Dose–response meta-analysis
  • GRADE
  • Melatonin
  • Systematic review
  • Dose-Response Relationship, Drug
  • Melatonin/administration & dosage
  • Humans
  • Fatigue/drug therapy
  • Neoplasms/complications
  • Dietary Supplements
  • Randomized Controlled Trials as Topic

Fingerprint

Dive into the research topics of 'Exploring the impact of melatonin on cancer-related fatigue: a dose-response meta-analysis with GRADE evidence evaluation'. Together they form a unique fingerprint.

Cite this